Interview mit Dr. Wilfried Stücker: Umdenken in der Medizin – Neuere Formen der Krebstherapie
/in IOZK Aktuelles, IOZK In der Presse /von IOZKDendritic cell therapy in cancer treatment; the state-of-the-art
/in Dendritic Cells, International Publications /von 2020-03-20 / Life Sci. 2020 Aug;254:117580The function and clinical application of extracellular vesicles in innate immune regulation
/in International Publications /von 2020-03-19 / Cell. Mol. Immunol. 2020 04;17(4):323-334A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
/in Hyperthermia, International Publications, NSCLC /von 2020-03-17 / J Adv Res 2020 Jul;24:175-182Prof. Dr. Volker Schirrmacher veröffentlicht zwei wegweisende Übersichtsartikel zur Immuntherapie
/in IOZK In der Presse, IOZK Veröffentlichungen /von IOZKCancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
/in International Publications, IOZK Veröffentlichungen /von 2020-03-16 / Biomedicines 2020 Mar;8(3)Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e9Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2020-03-12 / Front Oncol 2020;10:343Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
/in Dendritic Cells, Hyperthermia, International Publications /von 2020-03-12 / Pharmaceutics 2020 Mar;12(3)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution